Markers and histological types: p53 expression was found in 16% of the endometrioid and in 71% of the non-endometrial carcinomas (Figure 3); the estrogen and progesterone receptors were more frequent in the endometrioid type (Table 2). This evidence concerns the gene TP53 and endometrial carcinoma.